{"disease":{"id":"chronic-hepatitis-b-virus-infection","name":"chronic hepatitis b virus infection"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03944447","title":"Outcomes Mandate National Integration With Cannabis as Medicine","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":200000,"lead_sponsor_name":"OMNI Medical Services, LLC","has_results":false},{"nct_id":"NCT06596213","title":"Hepatitis Inequalities Study","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":100000,"lead_sponsor_name":"Chinese University of Hong Kong","has_results":false},{"nct_id":"NCT07258251","title":"Strengthening Hepatitis B Screening, Linkage to Care and Long-Term Monitoring in Phichit Province, Thailand: A Birth Bohort Approach","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":6000,"lead_sponsor_name":"The Task Force for Global Health","has_results":false},{"nct_id":"NCT07274345","title":"Prevalence and Risk Factors of Antiviral Resistance in Egyptian HBV Patients","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Amira Mohamed Zidan","has_results":false},{"nct_id":"NCT06874127","title":"Non-Invasive Model for Fibrosis Regression in HBV Patients","phase":"","overall_status":"RECRUITING","enrollment_count":1100,"lead_sponsor_name":"Beijing Friendship Hospital","has_results":false},{"nct_id":"NCT06906016","title":"New HBV Infection Biomarkers: Clinical Characterization and Impact on Management","phase":"","overall_status":"RECRUITING","enrollment_count":900,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT06544551","title":"Efficacy and Safety Study of Peginterferon Alfacon-2 to Treat Chronic Hepatitis B Virus Infection","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":336,"lead_sponsor_name":"Beijing Kawin Technology Share-Holding Co., Ltd.","has_results":false},{"nct_id":"NCT06537414","title":"A Study of Sequential Therapy With Daplusiran/Tomligisiran (DAP/TOM) Followed by Bepirovirsen in Participants Living With Chronic Hepatitis B (CHB)","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":283,"lead_sponsor_name":"GlaxoSmithKline","has_results":false},{"nct_id":"NCT05382351","title":"Antiviral Therapy for Patients With Chronic Hepatitis B Infection","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":238,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT05494528","title":"Comparing P1101 to Entecavir in Patients With HBeAg(-) Hepatitis B Under Long-term Nucleos(t)Ide Analogue Therapy","phase":"NA","overall_status":"UNKNOWN","enrollment_count":90,"lead_sponsor_name":"National Taiwan University Hospital","has_results":false},{"nct_id":"NCT07389044","title":"A Study on IB-001 Dose Response and Tolerability in Healthy Adults and Those With Chronic Hepatitis B","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":90,"lead_sponsor_name":"IntegerBio","has_results":false},{"nct_id":"NCT07519330","title":"Clinical Study to Evaluate the Efficacy and Safety of HH-006 in Patients With Chronic Hepatitis B Virus Infection","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":45,"lead_sponsor_name":"Huahui Health","has_results":false},{"nct_id":"NCT07515209","title":"A Clinical Study of HH-006 in Untreated Chronic Hepatitis B Virus Infected Patients","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"Huahui Health","has_results":false},{"nct_id":"NCT04971512","title":"A 2 PART STUDY EVALUATING EDP-721 IN HEALTHY SUBJECTS AND EDP-721 IN COMBINATION WITH EDP-514 IN PATIENTS WITH CHRONIC HEPATITIS B VIRUS INFECTION.","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":26,"lead_sponsor_name":"Enanta Pharmaceuticals, Inc","has_results":false},{"nct_id":"NCT06159062","title":"A Clinical Study of 162 in Subjects With Chronic Hepatitis B Virus Infection","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":1,"lead_sponsor_name":"Yangshengtang Co., Ltd","has_results":false}],"total":15},"guidelines":[],"source":"Drug Landscape verified database"}